Methods for determining peptidylglycine alpha-amidating monooxygenase (pam) and its use for diagnostic purpose
AssigneePAM Theragnostics GmbH
InventorAndreas Bergmann
Life of this patent
Estimating the term…
Abstract
The present invention is directed to methods for determining the level of PAM and/or its isoforms and/or fragments thereof in a bodily fluid or a tissue sample using an assay, wherein said assay is comprising at least one binder that is directed to a conformational epitope of PAM, and its use for diagnostic purpose.
Claims24
A method for determining the level of peptidylglycine alpha-amidating monooxygenase (PAM) and/or isoforms and/or fragments thereof in a sample of bodily fluid or a tissue using an assay, wherein said assay is comprising at least one binder that is directed to a conformational epitope of PAM.
Use of antibodies for determining the level of PAM and/or its isoforms and/or fragments thereof, wherein said antibodies are directed to a conformational epitope comprised within the following sequences of PAM:PHM fragment (amino acids 31-377 of PAM) (SEQ ID No. 25) and/or PAL fragment (amino acids 495-817 of PAM) (SEQ ID No. 8).
Kit for determining the level of PAM and/or its isoforms and/or fragments thereof, comprising one or more antibodies binding to PAM, which are directed to a conformational epitope comprised within the following sequences of PAM:PHM fragment (amino acids 31-377 of PAM) (SEQ ID No. 25) and/or PAL fragment (amino acids 495-817 of PAM) (SEQ ID No. 8).
Dependencies are inferred from the claim text.